Low-dose induction is an alternative way to start buprenorphine that avoids waiting for withdrawal to begin — increasingly used because standard timing has become less predictable with fentanyl in the drug supply.

The core idea

Instead of waiting for moderate withdrawal and then starting a full buprenorphine dose, this approach introduces very small amounts of buprenorphine while someone continues their usual opioid use, gradually increasing the buprenorphine dose over several days while the other opioid is tapered down or continues briefly — designed to avoid triggering precipitated withdrawal at any point in the process.

Why this has become more relevant

Fentanyl’s unpredictable accumulation in the body made the traditional “wait for withdrawal” approach less reliable — some people using fentanyl found that even after what should have been enough waiting time, starting a full buprenorphine dose still triggered precipitated withdrawal. Low-dose approaches sidestep this problem by never requiring a large jump in receptor activity at any single step.

What this looks like practically (general pattern — exact protocols vary)

A typical approach involves starting with a very small buprenorphine dose alongside continued use of the other opioid, then gradually increasing the buprenorphine dose over several days to a week or more, until a full treatment dose is reached — at which point the other opioid is no longer needed.

Why this needs a knowledgeable prescriber, not self-directed attempts

The specific dosing schedule requires clinical judgment and monitoring — this isn’t something to design based on a general description like this one. Not all prescribers are familiar with these newer protocols; if you’re interested in this approach, it’s worth asking a potential prescriber directly whether they have experience with low-dose or micro-dosing induction specifically.

The related, more formalized version of this approach

The Bernese method is a specific, published low-dose induction protocol. [that article]

Medically reviewed by [pending]. Sources: clinical literature on low-dose buprenorphine induction in the fentanyl era.